Popular weight loss drugs such as Mounjaro, Ozempic, and Wegovy have been linked to an increased risk of hair loss, according to researchers. The finding comes from a study that analyzed data on patients taking these medications, which are widely used for treating obesity and type 2 diabetes. The drugs belong to a class known as GLP-1 receptor agonists, which work by suppressing appetite and slowing digestion.
The study, reported by Sky News, suggests that hair loss is a potential side effect of these treatments. Researchers noted that while the risk appears to be elevated, the overall likelihood of experiencing hair loss remains low. They emphasized that the benefits of weight loss and blood sugar control may outweigh the risks for many patients.
The exact reason for the link is not yet clear. It may be related to rapid weight loss itself, which can sometimes trigger temporary hair shedding, or to direct effects of the medication. The study calls for further investigation to understand the mechanism better.
Doctors advise patients not to stop taking their medication without consulting a healthcare professional. Anyone concerned about hair loss while using these drugs should speak with their doctor. The findings add to a growing list of potential side effects associated with this popular class of drugs.